Oncology and Informatics – Editorial

Free Access

Introduction to the New Section “Oncology and Informatics”

Putora P.M. · Markman M.

Corresponding Author

PD Dr. Paul Martin Putora

Department of Radiation Oncology, Cantonal Hospital St. Gallen

Rorschacher Strasse 95

CH–9007 St. Gallen (Switzerland)

E-Mail PaulMartin.Putora@kssg.ch

Related Articles for ""

Oncology 2020;98:326

Oncology practice and research has been permeated and transformed by informatics – some changes have been very apparent and welcome, some occurred in the background without us noticing, and in some cases, we find ourselves dependent on informatics without ever having asked for it. With our new section “Oncology and Informatics” we would like to provide a forum within the journal to address the intersection between oncology and informatics.

This evolving field extends beyond the scope and expertise of any single individual; oncology informatics is multiprofessional by nature. The editors within the section will have different backgrounds and will aim to provide a balanced insight into this area. Due to this multiprofessional challenge, we will especially welcome manuscripts accessible to a more general audience. While this new section is open to all article types, we will start with a few reviews introducing various topics within oncology informatics to the readership.

Paul Martin Putora, St. Gallen, Switzerland

Maurie Markman, Philadelphia, PA, USA




Author Contacts

PD Dr. Paul Martin Putora

Department of Radiation Oncology, Cantonal Hospital St. Gallen

Rorschacher Strasse 95

CH–9007 St. Gallen (Switzerland)

E-Mail PaulMartin.Putora@kssg.ch


Article / Publication Details

Received: June 14, 2018
Accepted: June 14, 2018
Published online: September 25, 2018
Issue release date: June 2020

Number of Print Pages: 1
Number of Figures: 0
Number of Tables: 0

ISSN: 0030-2414 (Print)
eISSN: 1423-0232 (Online)

For additional information: https://beta.karger.com/OCL


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Stay Up to Date Banner Stay Up to Date Banner
TOP